Geneuity Releases Biomarker Assays for Early Detection of Kidney Damage

MARYVILLE, Tenn.--(BUSINESS WIRE)--Geneuity Clinical Research Services announces the recent validation and use in clinical trials of two human biomarker assays that play a key role in the early detection of kidney damage.